Status:
NOT_YET_RECRUITING
Efficacy of High-precision Transcranial Direct Current Stimulation on Anxiety Disorders
Lead Sponsor:
Nanjing Medical University
Conditions:
Anxiety Disorders
High-definition Transcranial Direct Current Stimulation
Eligibility:
All Genders
20-50 years
Phase:
NA
Brief Summary
1. Current research has found that tDCS has a positive effect on improving the negative attention bias of AD patients, and this study uses HD-tDCS intervention to improve the cognitive function and ne...
Eligibility Criteria
Inclusion
- Meet the DSM-5 AD diagnostic criteria;
- The Chinese version of the Brief International Neuropsychiatric Interview (MINI) screening meets the diagnosis;
- Age: 18-55 years old;
- The patient participated voluntarily, obtained the consent of the family members, and signed the informed consent form;
- Scale score criteria: 14 points on the Hamilton Anxiety Scale (HAMA) and 17 points on the Hamilton Depression Scale (HAMD).
Exclusion
- Neurological diseases or other psychiatric disorders;
- severe somatic diseases;
- received medical treatment including medication, psychotherapy, electroconvulsive therapy, and physical therapy within the first half months of enrollment;
- tDCS examination contraindications, such as intracranial metal or electronic implants, skull plate, or other skull implants.
- Pregnancy and lactation.
Key Trial Info
Start Date :
July 30 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06529341
Start Date
July 30 2024
End Date
December 30 2025
Last Update
July 31 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nanjing Brain Hospital
Nanjing, Jiangsu, China, 210024